Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Capital Expenditures Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Capital Expenditures
-$36.5m
CAGR 3-Years
17%
CAGR 5-Years
-16%
CAGR 10-Years
-27%
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.3B
CAGR 3-Years
17%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.3B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$94.6m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$369m
CAGR 3-Years
-34%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$617m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
-24%

See Also

What is Neogenomics Inc's Capital Expenditures?
Capital Expenditures
-36.5m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Capital Expenditures amounts to -36.5m USD.

What is Neogenomics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-27%

Over the last year, the Capital Expenditures growth was -39%. The average annual Capital Expenditures growth rates for Neogenomics Inc have been 17% over the past three years , -16% over the past five years , and -27% over the past ten years .

Back to Top